Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1022 | 972 | 923 | 1161 | 1090 | 1476 |
Fund Return | 2.18% | -2.83% | -7.72% | 5.11% | 1.73% | 3.97% |
Place in category | 5606 | 5805 | 5212 | 3223 | 2551 | 1417 |
% in Category | 86 | 89 | 88 | 72 | 76 | 79 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Bellevues Lux BB Adamant Medtech HC | 1.53B | 9.53 | -0.81 | 8.35 | ||
Baloise Inv Lux BFI Activ CHF R Acc | 168.63M | 1.77 | -0.57 | 0.44 | ||
Baloise Inv Lux BFI Dynamic CHF R A | 62.56M | 3.32 | 3.26 | 3.09 | ||
LU0415392165 | 34.21M | 12.26 | 0.07 | 3.10 | ||
LU0415392082 | 34.21M | 12.07 | -0.62 | 2.37 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Pictet Hi div Selection I CHF | 915.68M | 1.88 | -3.08 | - | ||
Pictet Hi div Selection I dy CHF | 915.68M | 1.88 | -3.07 | - | ||
Pictet Hi div Selection P CHF | 915.68M | 13.18 | -4.87 | 2.87 | ||
Pictet Hi div Selection P dy CHF | 915.68M | 13.18 | -4.87 | 2.88 | ||
Cap Group GlblEq lux A4 CHF | 771.79M | 8.70 | 8.65 | 10.82 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Nestle | CH0038863350 | 6.39 | 94.20 | +2.21% | |
iShares MSCI EM ESG Enhanced UCITS ETF USD Acc | IE00BHZPJ239 | 4.31 | 5.17 | 0.00% | |
Novartis | CH0012005267 | 3.98 | 90.54 | +0.85% | |
Roche Holding Participation | CH0012032048 | 3.97 | 222.30 | +0.45% | |
Richemont | CH0210483332 | 1.62 | 132.95 | +0.08% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Strong Buy | Buy |
Technical Indicators | Strong Sell | Strong Buy | BUY |
Summary | Neutral | Strong Buy | Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review